Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06063083
Other study ID # 20201189
Secondary ID K23MD015690
Status Recruiting
Phase N/A
First received
Last updated
Start date January 12, 2024
Est. completion date March 31, 2026

Study information

Verified date February 2024
Source University of Miami
Contact Audrey Harkness, PhD
Phone 3052841306
Email aharkness@miami.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be used to develop a program to help Latino men who have sex with men obtain pre-exposure prophylaxis (PrEP), HIV testing, and behavioral health services. The project will then involve a pilot test of this program with a community partner.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date March 31, 2026
Est. primary completion date March 31, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: - Identify as Latino/Hispanic - identify as a sexual minority man (e.g., gay, bisexual) and/or a man who has sex with men - age 18-39 years - English and/or Spanish speaking - self-report an HIV-negative or unknown HIV status - currently reside in the greater Miami area - PrEP eligible (based on Centers for Disease Control (CDC) criteria) and not currently taking PrEP - self-report experiencing one or more clinically significant behavioral health concerns (mental health, substance use) and are not currently receiving behavioral health services Exclusion Criteria: - Unable to provide consent - Opinion of the PI that the participant would be at risk for harm to self or others - Have a medical or psychiatric condition that would interfere with ability to participate in study procedures in the opinion of the PI - Involvement in any other HIV prevention or behavioral health study that may interfere with the ability to test major study outcomes (evaluated by the PI on a case-by-case basis)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tell Me More ("Dime Mas")
Participants will receive an initial approximately 1 hour outreach session followed by up to 3 approximately monthly check-in outreach attempts (approximately 15 minutes each). All study visits can be done in person or remotely. Each contact will involve helping participants get connected to PrEP, HIV testing, and behavioral health treatment.
Peer Ambassador Stories [Listen Miami ("Oye Miami")]
Participants will receive a link to a website featuring stories of local Latino MSM using PrEP, HIV testing, and behavioral health treatments. Participants will receive intermittent (based on personal choice) reminders to view the website. The website will also show referrals to services and provide the option to submit a story via written, video, or audio recording. Participants can access the website using a personal electronic device at any time during within the study period.
Standard Community Outreach
Participants will receive the standard community outreach, which will be a list of referrals for HIV testing, PrEP, and behavioral health treatments.

Locations

Country Name City State
United States University of Miami Coral Gables Florida

Sponsors (2)

Lead Sponsor Collaborator
University of Miami National Institute on Minority Health and Health Disparities (NIMHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in PrEP Uptake, as measured by the PrEP cascade questionnaire Participants will answer questions about interest and use of PrEP (e.g., receiving a prescription, taking PrEP), PrEP modality, PrEP adherence. A composite score will be calculated to determine whether or not the participant reach the "PrEP uptake" level of the PrEP cascade. A score of 1 means that the participant spoke to a provider and were prescribed medication for PrEP. A score of 0 means the participant did not. Baseline, 3 months, 6 months
Secondary Change in Behavioral Health Treatment Uptake, as measured by the Behavioral health cascade questionnaire (based on the Psychosocial Treatment Inventory) Participants will answer questions about interest and use of behavioral health treatment (e.g., number of sessions attended). A composite score will be calculated to determine whether or not the participant reach the "behavioral health treatment uptake" level of the behavioral health cascade. A score of 1 means that the participant received at least one session of behavioral health treatment in the last three months. A score of 0 means the participant did not. Baseline, 3 months, 6 months
Secondary Change in Recent (within the last 3 months) HIV testing Participants will answer a question about being tested in the past three months. A score of 1 means that the participant received at HIV test in the last three months. A score of 0 means the participant did not. Baseline, 3 months, 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2